Susanna Ulahannan MD

Medical Oncologist, Phase 1 trialist

[DrKatyMoore @DrKatyMoore]

I have been so fortunate thus far to spend my career caring for people with cancer and their families, building programs and helping to build leaders. I had the honor of building and maturing the @StephensonCC phase I unit, then mentoring/sponsoring @DebbieRic23 and @Phase1Onc who now lead the gyn onc division and phase 1 unit respectively! So proud of them.

[Susanna Ulahannan MD @Phase1Onc]

@DrKatyMoore @StephensonCC @DebbieRic23 It has been an absolute privilege to learn from you. You are an amazing clinician and mentor.

[Susanna Ulahannan MD @Phase1Onc]

First Results of STELLA Study: ART0380 (an ATR Kinase Inhibitor) With Low Dose Irinotecan in Advanced or Metastatic Solid Tumors | VuMedi https://t.co/uZYR4ENUgH via @vumedi

[Shreyas Kalantri, MD @KalantriShreyas]

Great talk on designing your first clinical trial @ASCOTECAG by @GuiNaderMarta ,@LindaVahdat @TheDrWood and @Phase1Onc. Thank you for answering my questions.

[Noha N. Soror, MD, MSc. 𓂀 @Noha_Soror]

#asco24 TEC sessions never fail to impress @Phase1Onc amongst 🌟 panel discussing “Designing Your First Clinical Trial” @ASCOTECAG @ResearchOU

[Dedipya Bhamidipati @drdedipya]

Another event @ASCOTECAG was the “Designing Your First Clinical Trial” with @GuiNaderMarta @LindaVahdat @TheDrWood and Dr. Ulahannan. Very exciting to hear perspectives on what is the best way to achieve grants, being resourceful and most importantly a team-player. #ASCO24

[Dionisia Quiroga, DO, PhD, FASCO @quirogad]

These panelists were such ⭐️rockstars⭐️ and did an amazing job speaking about #clinicaltrials, everyone wanted to talk to them more after the session ended!
@ASCOTECAG #ASCO24

[Guilherme Nader Marta @GuiNaderMarta]

“Research 101: Designing Your First Clinical Trial”

Don’t miss our panel on Sunday 6/2 from 11:00-11:45AM at #ASCO2024

@DFCI_BreastOnc

@ASCO @ASCOTECAG

@OncoAlert

[Anna M Brown, MD, MPhil (she/her) @jaguaranna27]

Excellent panel discussion at #ASCO24 on strategies for designing clinical trials featuring #RadOnc superstar @TheDrWood and other excellent #oncology researchers and clinicians. I love the #EarlyCareer focused programming available at @ASCO meetings and having a dedicated lounge helps create a wonderful platform for these wonderful topics 👏🙌

Also kudos to the @ASCOTECAG for the amazing new #EarlyCareer and Trainee lounge this year. 👌

My takeaways from the panel talk:
✅ Involve scientists, regardless of the trial type. Vital to give a lot of thought into the science behind the Qs. 👩‍🔬
✅ Involve biostatisticians, early and often 🤓📊
✅ Start small. Pilot studies can focus on precise questions that could form the foundation for a larger trial. 🌱↗️🪴
✅ Never underestimate the power of a grateful patient. More than we realize, patients may want to help, whether thru trial enrollment or even philanthropy 🙏
✅ In academics, negotiate for start-up seed funding to provide stability 💰
✅ If you don’t ask, the answer is going to be “no” — so be persistent & flexible

[Shearwood McClelland III, MD, FASCO @TheDrWood]

Starting soon (in 7 minutes) in the Trainee and Early Career Lounge!!
#RadOnc #ASCO24

[Susanna Ulahannan MD @Phase1Onc]

@TGeorgeMD @UFHealthCancer @theNCI Congratulations!

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Cannabis use among adults undergoing #cancer treatment.

https://t.co/98ewTjvDEW

@JournalCancer @StephensonCC @DesAzizoddin @henson_md @Phase1Onc @OUHealth @ResearchOU
#cannabisnews #PallOnc #SuppOnc

[OU Health Stephenson Cancer Center @StephensonCC]

Susanna Ulahannan, M.D., presenting: “Preliminary results from ERAS-007 plus palbociclib (palbo) in patients (pts) with KRAS/NRAS mutant (m) colorectal cancer (CRC) or KRASm pancreatic ductal adenocarcinoma (PDAC) in HERKULES-3 study.”

https://t.co/L7AldCxZ2W

#ASCO23

[OU Health Stephenson Cancer Center @StephensonCC]

Susanna Ulahannan, M.D., presenting “A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.”

https://t.co/kxzIySRFCc

#ASCO23

[OU Health Stephenson Cancer Center @StephensonCC]

Experts from @OUHealth Stephenson Cancer Center are attending @ASCO's conference this week.

With more than 200 sessions this event is a unique opportunity for international cancer experts to see latest innovations in cancer research and education. #ASCO23 https://t.co/vv6dtq46e8

[Doctor Ma’am @monicadonicaMD]

I know we have our priorities straight when we cancel Grand Rounds for the entire department so we can watch this instead 😂 @DGlaucomflecken